PPA
ITOS

Parametric Portfolio Associates’s iTeos Therapeutics ITOS Stock Holding History

Parametric Portfolio Associates’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.13M Sell
97,215
-26,759
-22% -$972K ﹤0.01% 2156
2021
Q4 		$5.77M Buy
123,974
+116,238
+1,503% +$3.87M ﹤0.01% 1761
2021
Q3 		$209K Buy
+7,736
New +$202K ﹤0.01% 3420

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Parametric Portfolio Associates's ITOS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its iTeos Therapeutics (ITOS) stake by 22% in Q1 2022, selling an estimated $972K and leaving 97,215 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Parametric Portfolio Associates first reported a position in ITOS in Q3 2021 and has held it in 3 quarters since. The position peaked at $5.77M in Q4 2021. 160 funds tracked by Wall St. Rank hold ITOS as of Q1 2022.

  • Parametric Portfolio Associates held 97,215 shares of iTeos Therapeutics worth $3.13M as of Q1 2022.
  • Parametric Portfolio Associates sold 26,759 iTeos Therapeutics shares in Q1 2022, an estimated $972K.
  • iTeos Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2156 holding.
  • Parametric Portfolio Associates first reported a position in iTeos Therapeutics in Q3 2021 and has held it in 3 quarters since.
  • Parametric Portfolio Associates's iTeos Therapeutics position peaked at $5.77M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.